MetaCap

ABVC BioPharma Statistics

NASDAQ: ABVCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.8663-0.0137 (-1.56%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ABVC BioPharma by the numbers

ABVC BioPharma has a market capitalization of $23.4 million based on 26.98M shares outstanding. With trailing EPS of $-0.20, ABVC BioPharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.3% below its 50-day average and 26.5% below its 200-day average.

Average daily trading volume is 81.92K shares, or about $70,966 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABVC valuation vs. peer median

ABVC compared with the median of 8 peer companies
MetricABVCPeer medianDifference
Market cap$23.37M$23.51M-1%
Avg. volume81.92K175.71K-53%

Peer median across 8 companies: SCYX, LITS, IXHL, RMTI, IMMP, CRVO, BCTX, TELO.

Valuation

Market cap
$23.37M
Price / sales (latest FY)
78.95
EPS (TTM)
$-0.20

Price and trading

Previous close
0.88
Open
0.917
Day range
0.85 – 0.917
52-week range
0.707 – 2.87
52-week change
-67.80%
Beta
—
Volume
39.05K

Dividends and events

Annual dividend
None
Next earnings date
Aug 12, 2025

Additional statistics

Market Cap
23.37M
Forward Pe
-1.97
Eps
-0.20
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.87
Week52 Low
0.71
Avg Volume
81,918.00
Shares Outstanding
26.98M
Ma50
1.01
Ma200
1.18
Earnings Date
Aug 12, 2025
Pct From52w High
-69.82%
Pct From52w Low
22.53%

Related